Hudis spoke with Paul Goldberg, editor and publisher of The Cancer Letter.
The American Society of Clinical Oncology has reached a deal that will allow two companies—Tempus and Precision Health AI—to curate and license the data in CancerLinQ, the professional society's venture into Big Data.
In 2017, The Cancer Letter's readership grew by over 40 percent and the number of page views has nearly doubled from the 2016 level.
About one in 225 to one in 580 women who undergo surgery for fibroids may have hidden uterine cancers, FDA concluded in a recent review of medical studies published over the past four years.
ST. JUDE MEMPHIS MARATHON WEEKEND Dec. 3 raised $10 million for St. Jude Children’s Research Hospital. Over the past 15 years, participants running as St. Jude Heroes have joined the fight against childhood cancer and raised more than $60 million to support St. Jude. About 23,000 people took part in the race that drew 40,000 […]
NOVOGENE, a commercial provider of genomic services, AITbiotech Pte Ltd, a Singapore biotechnology company, and the Genome Institute of Singapore announced that NovogeneAIT Genomics Singapore–a new joint venture between Novogene and AITbiotech–will establish a joint whole genome sequencing center at Biopolis, Singapore. The new center will provide Illumina HiSeq X based whole genome sequencing and […]
The U.S. Surgeon General Vivek Murthy today released a new report, E-Cigarette Use Among Youth and Young Adults. “We applaud the Surgeon General for bringing attention to the serious public health problem of youth use of e-cigarettes and the resulting adverse health effects,” said Chris Hansen, president of the American Cancer Society Cancer Action Network. […]
AbbVie signed separate five-year collaboration agreements with two cancer centers: the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Johns Hopkins University School of Medicine. The agreements are intended to advancing research and discovery in oncology. AbbVie and Northwestern will work in several areas of oncology research, which could include, lung, colorectal, […]
JOHN JENKINS will retire from his job as director of the FDA Office of New Drugs on Jan. 6, 2017. FDA will conduct a national search to fill his position. Janet Woodcock, director of the Center for Drug Evaluation and Research will serve as acting director of OND. Announcing Jenkins’s retirement, Woodcock wrote: For the […]
NANCY HESSE was named president and CEO of the Cancer Treatment Centers of America Eastern Regional Medical Center (Eastern) in Philadelphia. Hesse has served as interim president and CEO since February 2016, and before that as chief nursing executive for CTCA and chief nursing officer at Eastern. Hesse joined CTCA in 2014 after a long […]
